Synchronous onset of penile lichen sclerosus and vitiligo [19]

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 218-219

  Osborne, G E N ^a,b   Francis, N D ^b   Bunker, C B ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE;

ADULT; BIOPSY; CASE REPORT; HUMAN; LETTER; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PENIS DISEASE; PRIORITY JOURNAL; VITILIGO;

EID: 0033929156     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03635.x     Document Type: Letter

References (16)

1. 1 Leibowitch M. Lichen sclerosus. Semin Dermatol 1996 ; 15: 42–6.
2. 2 Tremaine RDL, Miller RAW. Lichen sclerosus et atrophicus. Int J Dermatol 1989 ; 28: 10–6.
3. 3 Meyrick Thomas RH, Ridley CM, Black M. Clinical features and therapy of lichen sclerosus affecting males. Clin Exp Dermatol 1987 ; 12: 126–8.
4. 4 Friedrich EG, Maclaren NK. Genetic aspects of vulvar lichen sclerosus. Am J Obstet Gynecol 1984 ; 150: 161–6.
5. 5 Marren P, Yell J, Charnock FM et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995 ; 132: 197–203.
6. 6 Wallace HJ. Lichen sclerosus et atrophicus. Trans St John’s Hosp Dermatol Soc 1971 ; 57: 9–30.
7. 7 Meyrick Thomas RH, Ridley CM, Black MM. The association between lichen sclerosus and autoimmune‐related disease in males. Br J Dermatol 1983 ; 109: 661–4.
8. 8 Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol 1981 ; 104: 563–6.
9. 9 Goolamali SK, Barnes EW, Irvine WJ et al. Organ‐specific antibodies in patients with lichen sclerosus. Br Med J 1974 ; 4: 78–9.
10. 10 Ridley CM. Lichen sclerosus: a review. Eur J Dermatol 1994 ; 4: 99–105.
11. 11 Cantwell AR Jr. Histologic observations of pleomorphic, variably acid‐fast bacteria in scleroderma, morphoea and lichen sclerosus et atrophicus. Int J Dermatol 1984 ; 23: 45–52.
12. 12 Ross SA, Sanchez JL, Taboas JB. Spirochetal forms in the dermal lesions of morphoea and lichen sclerosus et atrophicus. Am J Dermatopathol 1990 ; 12: 357–62.
13. 13 Bystryn JC. Immune mechanisms in vitiligo. Immunol Serv 1989 ; 46: 447–73.
14. 14 Norslund JJ, Lerner AB. Vitiligo: its relationship to systemic disease. Dermatology Update ( S. Moschete ed.) Amsterdam: Elsevier‐North Holland, 1979: 411–32.
15. 15 Moellman GE, Krass P, Halaban R et al. On the subject of serum antibodies to melanocytes in vitiligo. J Invest Dermatol 1985 ; 84: 333.
16. 16 Minden P, Sharpton TR, McClatchy JK. Shared antigens between human melanoma cells and mycobacterium bovis (BCG). J Immunol 1976 ; 116: 407–14.